Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma. (pnas.org)

Authors: Testa E … Rampioni Vinciguerra GL Journal: PNAS Published: 2026-05-05 DOI: https://doi.org/10.1073/pnas.2601788123